BARBI, Stefano
 Distribuzione geografica
Continente #
EU - Europa 3.534
NA - Nord America 3.508
AS - Asia 2.242
SA - Sud America 231
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 58
OC - Oceania 9
Totale 9.648
Nazione #
US - Stati Uniti d'America 3.425
RU - Federazione Russa 1.245
GB - Regno Unito 792
SG - Singapore 788
CN - Cina 754
IT - Italia 463
DE - Germania 217
VN - Vietnam 194
BR - Brasile 187
HK - Hong Kong 187
SE - Svezia 172
FR - Francia 147
FI - Finlandia 139
IE - Irlanda 129
KR - Corea 59
NL - Olanda 57
BD - Bangladesh 52
UA - Ucraina 48
CA - Canada 45
IN - India 39
ES - Italia 31
JP - Giappone 28
BE - Belgio 27
TR - Turchia 24
NG - Nigeria 20
IQ - Iraq 17
MX - Messico 17
ID - Indonesia 16
AR - Argentina 14
AT - Austria 13
ZA - Sudafrica 12
PL - Polonia 11
IR - Iran 10
AU - Australia 9
PK - Pakistan 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
CL - Cile 8
EC - Ecuador 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
LT - Lituania 6
MA - Marocco 6
TG - Togo 6
CH - Svizzera 5
KG - Kirghizistan 5
AZ - Azerbaigian 4
BJ - Benin 4
BY - Bielorussia 4
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
MY - Malesia 4
PY - Paraguay 4
TN - Tunisia 4
CO - Colombia 3
EG - Egitto 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
MD - Moldavia 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 9.587
Città #
Southend 687
Moscow 451
Singapore 432
Chandler 378
Dallas 352
Ashburn 335
San Jose 285
Jacksonville 262
Hong Kong 180
Ann Arbor 169
Woodbridge 141
Beijing 139
Dublin 129
Verona 124
Council Bluffs 117
Houston 102
New York 94
The Dalles 79
Munich 78
Los Angeles 61
Ho Chi Minh City 58
Shenyang 57
Nanjing 52
Jinan 48
Hanoi 47
Helsinki 47
Lawrence 43
Princeton 43
Wilmington 41
Hebei 35
Tianjin 33
Buffalo 28
Brussels 27
Orem 27
Tokyo 26
Turku 25
Milan 24
Rome 23
São Paulo 23
Changsha 22
Ningbo 22
Santa Clara 22
Frankfurt am Main 21
Guangzhou 21
London 21
Abuja 20
Nanchang 19
Denver 18
Madrid 18
Columbus 16
Zhengzhou 16
Phoenix 15
Sindelfingen 15
Amsterdam 14
Haikou 14
Jiaxing 13
Redondo Beach 13
Taiyuan 13
Atlanta 12
Boardman 12
Brooklyn 12
Chicago 12
Stockholm 12
Toronto 12
Fairfield 11
Montreal 11
Poplar 11
Taizhou 11
Warsaw 11
Bologna 10
Chennai 10
Dearborn 10
Hangzhou 10
Redmond 10
Seattle 10
Falkenstein 9
Johannesburg 9
San Francisco 9
Ankara 8
Mexico City 8
Paris 8
Boston 7
City of London 7
Dong Ket 7
Fuzhou 7
Jakarta 7
Kyiv 7
Mumbai 7
Norwalk 7
Nuremberg 7
Seoul 7
Tashkent 7
Baghdad 6
Bolzano 6
Haiphong 6
Hải Dương 6
Kent 6
Lomé 6
Rio de Janeiro 6
San José 6
Totale 5.998
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 379
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 304
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 289
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 289
Whole-genome landscape of pancreatic neuroendocrine tumours 286
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene terapy 233
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis 231
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 229
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 227
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 217
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 214
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy 213
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 208
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 206
Chromosome 3p alterations in pancreatic endocrine neoplasia 204
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 198
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 196
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 196
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 195
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 192
Reporting tumor molecular heterogeneity in histopathological diagnosis 192
Author Correction: The landscape of viral associations in human cancers 189
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 186
Molecular biology of neuroendocrine tumors 186
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 184
Divergent mutational processes distinguish hypoxic and normoxic tumours 183
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 179
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 178
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 175
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 175
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen 173
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 172
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 171
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 170
Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway 169
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphoma 167
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 166
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 166
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 161
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 154
Wnt (canonical and non canonical) pathways in breast carcinoma with extensive vascular invasion and inflammatory breast carcinoma 153
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 151
Author Correction: Pan-cancer analysis of whole genomes 142
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 138
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 135
Integrative pathway enrichment analysis of multivariate omics data 130
Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas 126
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 123
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 123
Mutazionidi PI3KCA nel cancro gastrico 113
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig 92
Molecular Biology of Neuroendocrine Tumors 20
Totale 9.648
Categoria #
all - tutte 29.710
article - articoli 23.702
book - libri 0
conference - conferenze 4.445
curatela - curatele 0
other - altro 916
patent - brevetti 0
selected - selezionate 0
volume - volumi 647
Totale 59.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 175 5 35 17 8 4 19 17 6 32 83
2022/2023911 64 120 86 145 82 220 8 58 100 2 13 13
2023/2024486 16 30 39 39 58 86 4 46 21 45 82 20
2024/20251.369 52 69 76 211 73 73 68 47 202 81 149 268
2025/20264.000 243 174 365 670 1.051 274 348 165 316 232 59 103
2026/2027125 41 84 0 0 0 0 0 0 0 0 0 0
Totale 9.648